Mais Informação
Acrónimo
IMPROVE_PRETERMInício
01 janeiro 2025Orçamento global
7.494.709,00 €
Estado
AtivoFim
31 dezembro 2028Responsável
Artur RochaFinanciamento
711.250,00 €
- Menu
- Passa a palavra.
Partilha esta página. - Linked in
- Copiar Url
-
IMPROVing lifElong health and development for children and adults born very PRETERM – observational studies to enhance randomised trials for comparative effectiveness research
The access to the final selection minute is only available to applicants.
Please check the confirmation e-mail of your application to obtain the access code.
